Maziarz, Richard T
550  results:
Search for persons X
?
1

Discovery of an Inherited Variant Associated with Susceptib..:

Zhu, Qianqian ; Herr, Megan ; Liang, Shuyi...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S99-S100 , 2024
 
?
 
?
3

Impact of ABO Compatibility on Outcomes after Allogeneic He..:

Murphy, Mikayla ; Yu, Yun ; Knight, Rebekah J...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S77 , 2024
 
?
4

Access to Allogeneic Hematopoietic Cell Transplant for Pati..:

Brouillard, Danielle ; Williamson, Staci ; Kamerman, LeeAnn...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S421-S422 , 2024
 
?
5

Medicare Utilization and Cost Trends for CAR-T Cell Therapi..:

Wu, James J ; Ghobadi, Armin ; Maziarz, Richard T....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S406-S407 , 2024
 
?
6

JAK1 Inhibition during CAR-T Cell Treatment Results in Redu..:

Pratta, Michael ; Volkova, Angelina ; DiPersio, John F....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S181-S182 , 2024
 
?
10

Long-Term Durable Responses in Patients with Relapsed/Refra..:

Awasthi, Rakesh ; Waldron, Edward ; Grupp, Stephan A....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S198-S199 , 2024
 
?
12

Defining the Optimal Post-CART Monitoring Period in Recipie..:

Wesson, William ; Riedell, Peter A. ; Porter, David L....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S206-S207 , 2024
 
?
 
?
15

POSTER: MDS-009 Enhanced Survival of Chronic Myelomonocytic..:

Niehus, Hunter ; Sabile, Jean ; Maziarz, Richard T....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S180 , 2023
 
1-15